Charlotte A Gaydos1, Michele-Corinne Ako2, Mitra Lewis2, Yu-Hsiang Hsieh2, Richard E Rothman3, Andrea F Dugas2. 1. Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD; Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD. Electronic address: cgaydos@jhmi.edu. 2. Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD. 3. Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD; Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD.
Abstract
STUDY OBJECTIVE: In emergency departments (EDs), diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae are challenging. We conducted a randomized clinical trial to assess rapid C trachomatis and N gonorrhoeae testing on overtreatment and undertreatment of women evaluated for C trachomatis and N gonorrhoeae. METHODS:Women undergoing pelvic examinations and C trachomatis and N gonorrhoeae testing (n=254) were randomized to control or rapid test groups. The control group received standard-of-care C trachomatis and N gonorrhoeae nucleic acid amplification tests of endocervical specimens, with 2- to 3-day turnaround times. For the rapid test group, clinicians collected an extra endocervical swab for GeneXpert C trachomatis and N gonorrhoeae rapid testing, in addition to the standard-of-care nucleic acid amplification test swab. Rapid results were immediately provided, and all patients were treated according to providers' clinical judgment. RESULTS: In the rapid test group, 7.9% of patients had positive test results for C trachomatis; 3.9% had positive test results for N gonorrhoeae. In the control standard-of-care group, 10.2% of patients had positive nucleic acid amplification test results for C trachomatis; 5.5% had positive results for N gonorrhoeae. Undertreatment for both C trachomatis and N gonorrhoeae in the ED was 0% for the rapid test group and 43.8% for the control standard-of-care group. Clinicians overtreated 46.5% of uninfected standard-of-care control patients for C trachomatis compared with 23.1% of uninfected rapid test patients. For patients uninfected with N gonorrhoeae, clinicians overtreated 46.7% of standard-of-care control patients compared with 25.4% of rapid test patients. The length of stay did not differ significantly between groups. CONCLUSION:Rapid C trachomatis and N gonorrhoeae testing in the ED led to a significant reduction in overtreatment for women without infections compared with the standard-of-care control group. Additionally, in the rapid test group there was significant improvement in appropriate treatment for patients with infections.
RCT Entities:
STUDY OBJECTIVE: In emergency departments (EDs), diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae are challenging. We conducted a randomized clinical trial to assess rapid C trachomatis and N gonorrhoeae testing on overtreatment and undertreatment of women evaluated for C trachomatis and N gonorrhoeae. METHODS:Women undergoing pelvic examinations and C trachomatis and N gonorrhoeae testing (n=254) were randomized to control or rapid test groups. The control group received standard-of-care C trachomatis and N gonorrhoeae nucleic acid amplification tests of endocervical specimens, with 2- to 3-day turnaround times. For the rapid test group, clinicians collected an extra endocervical swab for GeneXpert C trachomatis and N gonorrhoeae rapid testing, in addition to the standard-of-care nucleic acid amplification test swab. Rapid results were immediately provided, and all patients were treated according to providers' clinical judgment. RESULTS: In the rapid test group, 7.9% of patients had positive test results for C trachomatis; 3.9% had positive test results for N gonorrhoeae. In the control standard-of-care group, 10.2% of patients had positive nucleic acid amplification test results for C trachomatis; 5.5% had positive results for N gonorrhoeae. Undertreatment for both C trachomatis and N gonorrhoeae in the ED was 0% for the rapid test group and 43.8% for the control standard-of-care group. Clinicians overtreated 46.5% of uninfected standard-of-care control patients for C trachomatis compared with 23.1% of uninfected rapid test patients. For patients uninfected with N gonorrhoeae, clinicians overtreated 46.7% of standard-of-care control patients compared with 25.4% of rapid test patients. The length of stay did not differ significantly between groups. CONCLUSION: Rapid C trachomatis and N gonorrhoeae testing in the ED led to a significant reduction in overtreatment for women without infections compared with the standard-of-care control group. Additionally, in the rapid test group there was significant improvement in appropriate treatment for patients with infections.
Authors: Larissa May; Chelsea E Ware; Jeanne A Jordan; Mark Zocchi; Catherine Zatorski; Yasser Ajabnoor; Jesse M Pines Journal: Sex Transm Dis Date: 2016-05 Impact factor: 2.830
Authors: Colleen E Holley; Thuy Van Pham; Heather M Mezzadra; George C Willis; Michael D Witting Journal: Am J Emerg Med Date: 2015-06-12 Impact factor: 2.469
Authors: Charlotte A Gaydos; Barbara Van Der Pol; Mary Jett-Goheen; Mathilda Barnes; Nicole Quinn; Carey Clark; Grace E Daniel; Paula B Dixon; Edward W Hook Journal: J Clin Microbiol Date: 2013-03-06 Impact factor: 5.948
Authors: Yu-Hsiang Hsieh; Mitra K Lewis; Valentina G Viertel; Deanna Myer; Richard E Rothman; Charlotte A Gaydos Journal: Int J STD AIDS Date: 2020-09-30 Impact factor: 1.359
Authors: Barbara Van Der Pol; Stephanie N Taylor; Leandro Mena; Joel Lebed; Candice Joy McNeil; LaShonda Crane; Aaron Ermel; Adam Sukhija-Cohen; Charlotte A Gaydos Journal: JAMA Netw Open Date: 2020-05-01
Authors: Melissa B Miller; Faranak Atrzadeh; C A Burnham; Stephen Cavalieri; James Dunn; Stephen Jones; Charles Mathews; Peggy McNult; John Meduri; Chris Newhouse; Duane Newton; Michael Oberholzer; John Osiecki; David Pedersen; Nicole Sweeney; Natalie Whitfield; Joe Campos Journal: J Clin Microbiol Date: 2019-08-26 Impact factor: 5.948
Authors: Teodora Ec Wi; Francis J Ndowa; Cecilia Ferreyra; Cassandra Kelly-Cirino; Melanie M Taylor; Igor Toskin; James Kiarie; Nancy Santesso; Magnus Unemo Journal: J Int AIDS Soc Date: 2019-08 Impact factor: 5.396
Authors: Oriol Yuguero; Jose Manuel Fernández-Armenteros; Álvaro Vilela; Jesús Aramburu; Raquel Laín; Pere Godoy Journal: Front Public Health Date: 2021-02-22